Top Markets
#1 Black Phoenix Black Phoenix +354.49%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +75.51%
#4 Gold Park Gold Park +61.00%
#5 OpenEden OpenEden +38.44%
#6 Acurast Acurast +37.34%
#7 BasedHype BasedHype +27.03%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +21.32%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +20.03%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Pozycja w akcjach #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Cena akcji
$0.13607016
Ostatnia synchronizacja: 2024-09-10
Kapitalizacja rynkowa
$112.29K
Zmiana (1 dzień)
22.46%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel BiVictriX Therapeutics Plc (BVX)

Kategoria

Healthcare
Historia ceny akcji dla BiVictriX Therapeutics Plc (BVX)
Najwyższa cena zamknięcia: $0.11 dnia 2024-09-01

Najniższa cena zamknięcia: $0.30 dnia 2021-08-01
Historia cen akcji firmy BiVictriX Therapeutics Plc od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE